PrEP care for women with STIs at family planning clinics
Part of Infections clinical trials.
This study tests whether offering PrEP counseling to women with a recent STI at family planning clinics helps them start HIV prevention. Women who test positive for syphilis, gonorrhea, or chlamydia may be offered PrEP information and support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman (assigned female at birth).
- You recently tested positive for syphilis, gonorrhea, or chlamydia.
- You are seen at a Planned Parenthood of Illinois health center.
- You are interested in learning about PrEP (a pill to prevent HIV).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This study tests if combining sexually transmitted infection (STI) testing with HIV prevention medication (PrEP) helps control the HIV epidemic. It is for sexually active women aged 15-39 who live in Rakai and recently participated in a community health survey.
This study looks at ways to improve PrEP (pre-exposure prophylaxis) care by helping clinic staff track and support patients better. It's for healthcare workers, managers, and data staff at certain PrEP clinics.
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
This study tests a program to help women at risk for HIV get PrEP, a medicine that prevents HIV. It focuses on women who may want to have a child or have been pregnant recently.
This trial tests a program where HIV testing counselors help family planning patients learn about and get PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to access in clinics you may already visit.
Hear when a new PrEP Uptake trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.